Rephonic
Artwork for Research To Practice

Research To Practice | Oncology Videos

Dr Neil Love
Immunotherapy
Multiple Myeloma
Clinical Trials
Antibody-Drug Conjugates
Ovarian Cancer
Colorectal Cancer
Prostate Cancer
Breast Cancer
CAR T-Cell Therapy
Acute Myeloid Leukemia
PARP Inhibitors
Chemotherapy
Chronic Lymphocytic Leukemia
Non-Hodgkin Lymphoma
Small Cell Lung Cancer
Pembrolizumab
Antibody Drug Conjugates
ESR1 Mutations
Her2-Positive Breast Cancer
Metastatic Breast Cancer

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.

PublishesDailyEpisodes1524Founded13 years ago
Number of ListenersCategories
Health & FitnessScienceMedicine

Listen to this Podcast

Artwork for Research To Practice

Latest Episodes

Featuring perspectives from Dr Terence Friedlander and Dr Daniel P Petrylak, including the following topics:

• Introduction (0:00)

• Role of Immunotherapeutic Strategies in the Management of Nonmetastatic Urothelial Bladder Cancer (UBC); Emerging... more

Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topics:

• Introduction (0:00)

• Strategies to Identify Patients with HER2-Positive Gynecologic Cancers — D... more

Featuring perspectives from Dr John N Allan and Dr Adam Kittai, including the following topics:

• Introduction (0:00)

• Current Management of Newly Diagnosed Chronic Lymphocytic Leukemia — Dr Allan (8:47)

• Noncovalent Bruton Tyrosine Kinase Inh... more

Featuring perspectives from Dr Neeraj Agarwal, Dr Elisabeth I Heath, Dr Daniel P Petrylak, Dr Fred Saad and Dr Neal D Shore, moderated by Dr Heath, including the following topics:

• Introduction (0:00)

• Evolving Management of Nonmetastatic Hormo... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)
Plenary Session
Plenary SessionVinay Prasad, MD MPH

Recent Guests

Sandy Srinivas
Guest contributing second opinion comments
Unknown from transcript
Episode: Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
Rana McKay
Guest contributing second opinion comments
Unknown from transcript
Episode: Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
Andrew Armstrong
Guest contributing second opinion comments
Duke University (as referenced in discussion)
Episode: Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
Robert Motzer
Guest contributing second opinion comments
Memorial Sloan Kettering Cancer Center
Episode: Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
Sara Hurvitz
Faculty member providing clinical perspectives on HR-positive metastatic breast cancer
Fred Hutchinson Cancer Center
Episode: HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy
Jacob Sands
Dr. Jacob Sands from the Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
Christine Hann
Dr. Christine Hann from the Sydney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine
Johns Hopkins University
Episode: Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
Bernd Kasper
Professor from the University of Heidelberg and Mannheim Cancer Center
University of Heidelberg / Mannheim Cancer Center
Episode: Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper
Thomas Powles
Professor at Barts Cancer Institute, Queen Mary University of London
Barts Cancer Institute, Queen Mary University of London
Episode: Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Host

Neil Love
Host of multiple expert discussions and reviewer guides within the series.

Reviews

4.6 out of 5 stars from 150 ratings
  • Valued resource

    Relentless in its focus on the general medical oncolgist. An important resource.

    Apple Podcasts
    5
    a h/o
    United States5 years ago
  • Excellent

    Since my fellowship training Neil Love has made these presentations the best of the best in staying UpToDate with current and future practice

    Apple Podcasts
    5
    obete man
    United States5 years ago
  • RTP is is consistently great

    Research to Practice continues to put out well produced clinically relevant content from expert faculty that is applicable to daily oncology practice. It is an invaluable resource for me.

    Apple Podcasts
    5
    OKMedStudent
    United States5 years ago
  • Gold standard

    I’m not an oncologist but I love listening to all of these podcasts. I have to imagine that Neil Love is an absolute giant in this field. So interesting and informative.

    Apple Podcasts
    5
    Bob a la sob mob
    United States7 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Valuable resource for staying current with medical oncology practice.
Consistently high-quality, well-produced content with clinically relevant insights.
Listeners praise practical guidance and expert faculty across episodes.
Long-form discussions are appreciated for depth and credibility.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#223
United States/Science
Apple Podcasts
#19
United Arab Emirates/Science
Apple Podcasts
#22
Indonesia/Science
Apple Podcasts
#101
India/Science
Apple Podcasts
#167
China/Science
Apple Podcasts
#178
Brazil/Science

Talking Points

Recent interactions between the hosts and their guests.

Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
Q: Which risk stratification models do you utilize?
Panelists discussed using the Assure nomogram and other models (e.g., UCLA TNM-based strata, Mayo S-SSign) to estimate five-year disease-free survival and overall survival, while noting limitations and the need to tailor use to patient context.
Ovarian Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer
Q: What about using a PARP inhibitor after a prior PARP inhibitor exposure in the frontline setting?
Re-treatment with a PARP inhibitor can be considered in selected cases, especially with time off treatment and good response to prior platinum; data are evolving, and individual patient factors guide this choice.
Ovarian Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer
Q: Is bevacizumab beneficial when combined with PARP inhibitors in frontline maintenance?
Evidence is not definitive; there are indirect comparisons suggesting possible additive benefit in some subgroups, but randomized prospective data are needed to establish the true value of adding bevacizumab.
Ovarian Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer
Q: How should upfront maintenance be approached in patients with BRCA mutation or HRD deficiency?
Maintenance decisions should be individualized based on BRCA/HRD status, overall disease burden, and feasibility of adding anti-angiogenic therapy; HRD positivity and BRCA mutation predict PARP inhibitor benefit, and decisions also depend on response to platinum and risk stratification.
PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida
Q: What is the rationale for using niraparib upfront with abiraterone in BRCA2-mutant patients, and what endpoints drive that decision?
The rationale is that upfront combination therapy may yield longer progression-free survival and potential overall survival benefits beyond sequential therapy, and the decision is driven by endpoints showing impressive upfront PFS and signals of OS improvement, balanced against tolerability and patient fitness.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Research To Practice

What is Research To Practice about and what kind of topics does it cover?

This program curates expert-led discussions that translate the latest oncology evidence into practical guidance for clinicians. Episodes span solid tumors and hematologic cancers, with deep dives into targeted therapies, biomarker-driven treatment decisions, trial data, and evolving standard-of-care strategies. Guests are often leading oncologists from major cancer centers who interpret complex studies, compare therapeutic options, and discuss real-world considerations such as toxicity management and sequencing of therapies. A standout strength is the evidence-rich, clinically oriented lens, frequently anchored by long-running series and year-in-review formats that foreground emerging data and its implications for daily practice.

Where can I find podcast stats for Research To Practice?

Rephonic provides a wide range of podcast stats for Research To Practice. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Research To Practice and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Research To Practice get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Research To Practice, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Research To Practice?

Rephonic provides comprehensive predictive audience data for Research To Practice, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Research To Practice have?

To see how many followers or subscribers Research To Practice has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Research To Practice?

These podcasts share a similar audience with Research To Practice:

1. Two Onc Docs
2. ASCO Daily News
3. Oncology Today with Dr Neil Love
4. Oncology Brothers: Practice-Changing Cancer Discussions
5. Plenary Session

How many episodes of Research To Practice are there?

Research To Practice launched 13 years ago and published 1524 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Research To Practice?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Research To Practice?

Rephonic pulls ratings and reviews for Research To Practice from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Research To Practice?

Rephonic provides full transcripts for episodes of Research To Practice. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Research To Practice?

Recent guests on Research To Practice include:

1. Sandy Srinivas
2. Rana McKay
3. Andrew Armstrong
4. Robert Motzer
5. Sara Hurvitz
6. Jacob Sands
7. Christine Hann
8. Bernd Kasper

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days